about
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nea...
Read More
40.60
-0.52
(-1.26%)
2.0M
XNYS Volume
XNYS 13 Mar, 2026 5:30 PM (EDT)
Analyst Upgrade
Deutsche Bank upgrades Qiagen NV to a 'Buy' rating; cites an attractive valuation
See details
Medium Financial Strength
Affordable Valuation
Technically Bearish
Falling Comet
These stocks are medium quality with average financials. However, their weak momentum indicates low investor interest
View Similar
Embed DVM
Qiagen NV Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..